Here’s What You Need to Know About Cannabis and Cognitive Decline
Almost 50 million Americans each year use some form of cannabis. In the 1920s, the drug was vilified because of recreational use by Mexican…
Almost 50 million Americans each year use some form of cannabis. In the 1920s, the drug was vilified because of recreational use by Mexican…
Will experimental drug lecanemab be safe and effective in treating Alzheimer’s? Being Patient shares what we know so far, and asks experts for direct…
AmyriAD Therapeutics CEO Sharon L. Rogers shares the scoop on AmyriAD’s investigational Alzheimer’s drug AD101. The majority of experimental Alzheimer’s drugs are being designed…
Drugmaker Eli Lilly says experimental Alzheimer’s drug remternetug is part of the next generation of anti-amyloids. The approval of the controversial anti-amyloid drug Aduhelm…
New trial data presented at CTAD shows drug brexpiprazole is effective at treating agitation in people with Alzheimer’s dementia. The FDA may consider it…
In Phase 3 trials, Roche’s experimental Alzheimer’s drug gantenerumab has failed to meet its objectives for slowing cognitive decline. Most Alzheimer’s treatments on the market…
Some of the most common treatments for Alzheimer’s symptoms may be prescribed in pill form, as an oral solution, or even as a transdermal…